Immunity By Design

Why ImmSilico?

The Challenge: Great Ideas, Complex Execution

You have compelling immunological hypotheses — perhaps investigating the role of rare cell populations in a disease — but translating these ideas into robust experimental designs is where the challenge lies. How do you choose the right experimental technology to allow you capture enough of those rare cells -- while in your budget limit -- to achieve statistical power? How do you design elegant experiments to maximise signal to noise ratio? What about downstream data interpretations, machine-learning and AI modeling, new hypothesis generation and functional validation?

We Decode Principles, Not Just Patterns

At ImmSilico, we sit at the intersection of immunology, experimental innovation, data science techniques and  artificial intelligence modelling of immunological data. Our expertise goes beyond analytics — we help decode the principles that drive tissue-level immune responses and translate them into actionable therapeutic insights.

We're not just analysts — we're co-thinkers.

What Makes Us Different

Rare Expertise at the Right Intersection
Our highly selective, multidisciplinary team spans computational biology, systems T cell immunology, structural immunology, wet lab sciences, and machine learning. This unique combination allows us to design experiments knowing exactly what the downstream analysis will reveal, and interpret results through the lens of both molecular mechanisms and therapeutic potential.

Pioneering Methodological Edge
We're at the forefront of emerging single-cell and spatial technologies, specializing in antigen-specific T cell modelling and immune repertoire profiling. While others analyze general immune responses, we help to crack the underly grammar of T cell immunity time and space, revealing how targeted immune responses can be therapeutically harnessed.

Proven Speed and Industry Translation
Our publication record in Cancer Cell, Nature Medicine, and Cell demonstrates our ability to move rapidly from hypothesis to breakthrough insights. As scientists with extensive pharmaceutical collaboration experience, we bridge academic rigor with commercial reality — delivering discoveries that advance both scientific understanding and therapeutic development.

The ImmSilico Advantage

Whether you need scientific validation of a specific technique for your grant application, expert guidance on executing your project with optimal technology, strategic advice on translational potential of new discoveries, or as a funding body seeking unbiased professional evaluation of consortium-level proposals, ImmSilico is delighted to act as your trusted partner.

Our consultancy empowers researchers, teams, and funding organizations to design better experiments, ask deeper questions, and uncover insights that transform immune health outcomes.

Ready to move from data to discovery?